info@infond.si
VEP as of 27.03.2024
47,07 EUR
1,42%
PERFORMANCE as of 27.03.2024
| 1 Year | 11,72% |
| 3 Years | 27,50% |
| 5 Years | 46,99% |
RISK AND REWARD PROFILE
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
|
|
| LOWER RISK | HIGHER RISK |
Investment Focus
Infond Zdravstvo, equity subfund of Infond Umbrella fund invests mainly in the shares of sectorally limited portfolios of companies from the Healthcare sector.
(Pharmaceuticals and biotechnology, medical equipment industry, service providers e.g. wholesalers, laboratory services and companies operating hospitals, care homes and homes for the elderly…)
Calendar year performance
2008
-13,13%
14,09%
2009
11,19%
2010
4,81%
2011
13,14%
2012
28,65%
2013
30,93%
2014
14,08%
2015
2016
-6,29%
1,61%
2017
7,07%
2018
21,72%
2019
2020
-2,85%
24,73%
2021
1,73%
2022
2023
-2,57%
8,63%
2024
Displayed are Performances from beginning to the end of each calendar year. Performance in the current year is shown for the period from the start of the calendar year up to the date of the currently published NAV.
Performance 12 Month periods
as of 27.03.2024
| PERIOD | PERFORMANCE |
|---|---|
| 27.03.2023 - 27.03.2024 | 11,72% |
| 27.03.2022 - 27.03.2023 | -3,92% |
| 27.03.2021 - 27.03.2022 | 20,79% |
| 27.03.2020 - 27.03.2021 | 18,26% |
| 27.03.2019 - 27.03.2020 | -4,39% |
Past performance does not predict future returns. MORE...
The risk indicator is based on the assumption that investor holds the fund for at least 5 years.
The summary risk indicator is a guide to the level of risk of this product compared to other products. It shows how likely it is that the product will lose money because of movements in the markets or because we are not able to pay you.
We have classified the fund as 4 out of 7, which is a medium risk class. The summary risk indicator is based on an estimate of the magnitude of fluctuations in the value of the asset unit. Depending on the fund's operations in the future, the summary risk indicator may change. The lowest category does not mean a risk-free investment.
The Fund does not use any protection for future market performance, so you may lose all or part of your investment.
The summary risk indicator is a guide to the level of risk of this product compared to other products. It shows how likely it is that the product will lose money because of movements in the markets or because we are not able to pay you.
We have classified the fund as 4 out of 7, which is a medium risk class. The summary risk indicator is based on an estimate of the magnitude of fluctuations in the value of the asset unit. Depending on the fund's operations in the future, the summary risk indicator may change. The lowest category does not mean a risk-free investment.
The Fund does not use any protection for future market performance, so you may lose all or part of your investment.
TYPE OF SUB-FUND
equity sub-fund of the health sector
FUND INCEPTION DATE
04.06.2007
TRADING REGION
SI
SIZE OF FUND
39,87 mio EUR (as of 29.02.2024)
IBAN
SI56 1010 0005 6546 436
ISIN
SI 0021400526
LEI
950400HMN29NTS7V9H52
GIIN (FATCA)
JEQ640.00015.SF.705
BASE CURRENCY
EUR
CUSTODIAN
Banka Intesa Sanpaolo, d.d.
DEALING
daily
MAX. INITIAL CHARGE
3,00%
MAX. REDEMPTION FEE
0,00%
MANAGEMENT FEE
2,25%
RISK AND REWARD PROFILE
as of
| FUND | PERFORMANCE (displayed in a chart) |
TYPE OF SUB-FUND | OBJECTIVES AND INVESTMENT POLICY | BASE CURRENCY | ||
|---|---|---|---|---|---|---|
|
|
Infond Zdravstvo | 0% | Equity Fund | Sector | EUR | |
|
|
/ | / | / | / | ||
Performance
as of 27.03.2024
| PERIOD | PERFORMANCE | YEARLY |
|---|---|---|
| 1 Month | 0,68% | / |
| 3 Months | 9,25% | / |
| 6 Months | 8,62% | / |
| Current year (YTD) | 8,63% | / |
| 1 year | 11,72% | / |
| 3 years | 27,50% | 8,44% |
| 5 year | 46,99% | 8,01% |
| 10 year | 130,71% | 8,72% |
| Since inception | 275,97% | / |
Past performance does not predict future returns. MORE...
Performance 12 Month periods
as of 27.03.2024
| PERIOD | PERFORMANCE |
|---|---|
| 27.03.2023 - 27.03.2024 | 11,72% |
| 27.03.2022 - 27.03.2023 | -3,92% |
| 27.03.2021 - 27.03.2022 | 20,79% |
| 27.03.2020 - 27.03.2021 | 18,26% |
| 27.03.2019 - 27.03.2020 | -4,39% |
The risk indicator is based on the assumption that investor holds the fund for at least 5 years.
The summary risk indicator is a guide to the level of risk of this product compared to other products. It shows how likely it is that the product will lose money because of movements in the markets or because we are not able to pay you.
We have classified the fund as 4 out of 7, which is a medium risk class. The summary risk indicator is based on an estimate of the magnitude of fluctuations in the value of the asset unit. Depending on the fund's operations in the future, the summary risk indicator may change. The lowest category does not mean a risk-free investment.
The Fund does not use any protection for future market performance, so you may lose all or part of your investment.
The summary risk indicator is a guide to the level of risk of this product compared to other products. It shows how likely it is that the product will lose money because of movements in the markets or because we are not able to pay you.
We have classified the fund as 4 out of 7, which is a medium risk class. The summary risk indicator is based on an estimate of the magnitude of fluctuations in the value of the asset unit. Depending on the fund's operations in the future, the summary risk indicator may change. The lowest category does not mean a risk-free investment.
The Fund does not use any protection for future market performance, so you may lose all or part of your investment.
10 Largest Holdings
as of 29.02.2024
| NAME | % OF FUNDVOLUME |
|---|---|
| ELI LILY & CO | 8,50% |
| UNITEDHEALTH | 6,13% |
| NOVO NORDISK | 5,49% |
| MERCK & CO | 4,59% |
| ROCHE HOLDING | 3,66% |
| ABBVIE | 3,43% |
| ASTRAZENECA | 3,30% |
| BOSTON SCIENTIFIC | 3,10% |
| ABBOTT LABORATORIES | 3,06% |
| THERMO FISHER SCIENTIFIC | 2,85% |
Asset allocation
as of 29.02.2024
| FUND | % OF FUNDVOLUME | |
|---|---|---|
| Stocks | 89,33% | |
| Open-end investment funds | 7,63% |
Geographic allocation
as of 29.02.2024
| FUND | % OF FUNDVOLUME | |
|---|---|---|
| USA | 72,22% | |
| Switzerland | 5,52% | |
| Denmark | 5,49% | |
| Great Britain | 3,74% | |
| France | 2,01% | |
| China | 1,30% | |
| Australia | 1,29% | |
| Japan | 1,04% | |
| Ireland | 0,94% | |
| Other | 3,41% |
Sector allocation
as of 29.02.2024
| FUND | % OF FUNDVOLUME | |
|---|---|---|
| Brand name drugs | 39,88% | |
| Medical equipment | 17,92% | |
| Medical services | 15,65% | |
| Biotechnology | 14,65% | |
| Life sciences tools&services | 7,92% | |
| Health care technology | 0,61% | |
| Other | 0,33% |
Objectives and investment policy
Infond Zdravstvo is an equity subfund that invests at least 80 % of its assets in equities from healthcare sector without geografical limitation.
It is intended for investors who are willing to assume higher risk and invest their funds over the long term, but at the same time expect higher gains than with less risky types of investments. Our estimate is that it is highly appropriate as a supplement to personal investments.
- At least 85 % of sub-fund's assets are invested in shares or in shares and units of equity target funds.
- At least 80 % of sub-fund’s assets are in company shares or in shares and units of equity target funds, which invest in company shares, which belong to the health sector.
It is intended for investors who are willing to assume higher risk and invest their funds over the long term, but at the same time expect higher gains than with less risky types of investments. Our estimate is that it is highly appropriate as a supplement to personal investments.
About Sava Infond
KBM Infond, Management Company Ltd. is a Slovenian investment fund management company, which was incorporated in year 1993. KBM Infond, Ltd. is part of the Nova KBM, Plc. banking group. Nova KBM, the second largest Slovenian bank.
Currently KBM Infond Ltd. manages Infond Umbrella Fund with 18 subfunds, Infond Umbrella Fund with 6 subfunds and Infond Smart Quality mutual fund, with assets in excess of 300 million Euros. This level of assets gives KBM Infond Ltd. the distinction of being one of the largest fund managers in Slovenia with 12,5% market share.
As one of the main fund managers in Slovenia, KBM Infond, Ltd. managing profitably a wide range of funds for twenty years. Today, KBM Infond Ltd. is a stable fund management company in the Slovenian market and possesses all the professional standards of practice, conditions, infrastructure and managerial skills necessary for a successful asset management.
The funds managed by our company are currently offered and distributed within domestic and some European markets (Austria, Czech Republic and Slovakia). However, we plan to distribute our mutual funds also in other European countries.
TYPE OF SUB-FUND
equity sub-fund of the health sector
FUND INCEPTION DATE
04.06.2007
TRADING REGION
SI
SIZE OF FUND
39,87 mio EUR (as of 29.02.2024)
IBAN
SI56 1010 0005 6546 436
ISIN
SI 0021400526
LEI
950400HMN29NTS7V9H52
GIIN (FATCA)
JEQ640.00015.SF.705
BASE CURRENCY
EUR
CUSTODIAN
Banka Intesa Sanpaolo, d.d.
DEALING
daily
MAX. INITIAL CHARGE
3,00%
MAX. REDEMPTION FEE
0,00%
MANAGEMENT FEE
2,25%
RISK AND REWARD PROFILE
TYPE OF SUB-FUND
equity sub-fund of the health sector
FUND INCEPTION DATE
04.06.2007
TRADING REGION
SI
SIZE OF FUND
39,87 mio EUR (as of 29.02.2024)
IBAN
SI56 1010 0005 6546 436
ISIN
SI 0021400526
LEI
950400HMN29NTS7V9H52
GIIN (FATCA)
JEQ640.00015.SF.705
BASE CURRENCY
EUR
CUSTODIAN
Banka Intesa Sanpaolo, d.d.
DEALING
daily
MAX. INITIAL CHARGE
3,00%
MAX. REDEMPTION FEE
0,00%
MANAGEMENT FEE
2,25%
RISK AND REWARD PROFILE
The value of investments will fluctuate, which will cause fund prices to fall as well as rise and you may not get back the original amount you invested. The level of any income earned by the fund will fluctuate. Past performance is not a guide to future performance. The value and any income arising from any investment referred to on this Site may go down as well as up. In particular you may not get back the full amount invested. Where overseas securities are held the rate of currency exchange may cause the value of the investment to go up as well as down. Any forecast, projection or target is indicative only and is not guaranteed in any way. We accept no liability for any failure to meet such a forecast, projection or target. Important information.
080 22 42